TRPM4 non-selective cation channel variants in long QT syndrome

BMC Medical Genetics

Volumn 18, Issue 1, 2017, Pages

  Hof, Thomas ^a   Liu, Hui ^b,c,g   Sallé, Laurent ^a   Schott, Jean Jacques ^d   Ducreux, Corinne ^e   Millat, Gilles ^c   Chevalier, Philippe ^e   Probst, Vincent ^d,f   Guinamard, Romain ^a   Bouvagnet, Patrice ^b,c,e,h  

^a France   (France)

^b UNIVERSITÉ LYON 1   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d CNRS   (France)

^e LOUIS PRADEL HOSPITAL   (France)

^f NANTES UNIVERSITY HOSPITAL   (France)

^g HAINAN MEDICAL UNIVERSITY   (China)

^h Groupe Hospitalier Est   (France)

Author keywords

Arrhythmia; Electrophysiology; Gene mutation; Long QT syndrome; Outward rectifying current; TRPM4

Indexed keywords

INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; PANTOTHENATE KINASE 2; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNE2; POTASSIUM CHANNEL KCNQ1; SODIUM CHANNEL NAV1.5; TRANSIENT RECEPTOR POTENTIAL CHANNEL M4; VOLTAGE GATED SODIUM CHANNEL BETA 4 SUBUNIT; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRPM4 PROTEIN, HUMAN;

ADOLESCENT; AGED; ARTICLE; CASE REPORT; CHILD; CONTROLLED STUDY; CYANOSIS; DIZZINESS; DYSPNEA; ELECTROPHYSIOLOGY; EXON; FAINTNESS; FEMALE; GENE; GENETIC VARIABILITY; HEART FAILURE; HEART VENTRICLE EXTRASYSTOLE; HETEROZYGOTE; HUMAN; HYPERTENSION; HYPERTROPHY; HYPOKALEMIA; HYPOTHERMIA; KCNH2 GENE; KCNQ1 GENE; LONG QT SYNDROME; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATENT FORAMEN OVALE; QT PROLONGATION; SCN5A GENE; SEIZURE; T WAVE; TRPM4 GENE; VOMITING; WILD TYPE; ADULT; AMINO ACID SUBSTITUTION; GENETICS; INFANT; MIDDLE AGED; PATHOPHYSIOLOGY; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LONG QT SYNDROME; MALE; MIDDLE AGED; TRPM CATION CHANNELS; YOUNG ADULT;

EID: 85015688744     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/s12881-017-0397-4     Document Type: Article

References (29)

1. Schwartz PJ, Stramba-Badiale M, Crotti L, Pedrazzini M, Besana A, Bosi G, et al. Prevalence of the congenital long-QT syndrome. Circulation. 2009;120:1761-7.
2. Zumhagen S, Stallmeyer B, Friedrich C, Eckardt L, Seebohm G, Schulze-Bahr E. Inherited long QT syndrome: clinical manifestation, genetic diagnostics, and therapy. Herzschrittmacherther Elektrophysiol. 2012;23:211-9.
3. Amin AS, Pinto YM, Wilde AAM. Long QT syndrome: beyond the causal mutation. J Physiol. 2013;591:4125-39.
4. Nakano Y, Shimizu W. Genetics of long-QT syndrome. J Hum Genet. 2016;61:51-5.
5. Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm. 2011;8:1308-39.
6. Launay P, Fleig A, Perraud AL, Scharenberg AM, Penner R, Kinet JP. TRPM4 is a Ca2 + -activated nonselective cation channel mediating cell membrane depolarization. Cell. 2002;109:397-407.
7. Guinamard R, Chatelier A, Demion M, Potreau D, Patri S, Rahmati M, et al. Functional characterization of a Ca(2+)-activated non-selective cation channel in human atrial cardiomyocytes. J Physiol. 2004;558:75-83.
8. Demion M, Thireau J, Gueffier M, Finan A, Khoueiry Z, Cassan C, et al. Trpm4 gene invalidation leads to cardiac hypertrophy and electrophysiological alterations. PLoS One. 2014;9:e115256.
9. Kruse M, Schulze-Bahr E, Corfield V, Beckmann A, Stallmeyer B, Kurtbay G, et al. Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I. J Clin Invest. 2009;119:2737-44.
10. Liu H, El Zein L, Kruse M, Guinamard R, Beckmann A, Bozio A, et al. Gain-of-function mutations in TRPM4 cause autosomal dominant isolated cardiac conduction disease. Circ Cardiovasc Genet. 2010;3:374-85.
11. Liu H, Chatel S, Simard C, Syam N, Salle L, Probst V, et al. Molecular genetics and functional anomalies in a series of 248 Brugada cases with 11 mutations in the TRPM4 channel. PLoS One. 2013;8:e54131.
12. Tfelt-Hansen J, Winkel BG, Grunnet M, Jespersen T. Inherited cardiac diseases caused by mutations in the Nav1.5 sodium channel. J Cardiovasc Electrophysiol. 2010;21:107-15.
13. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191-4.
14. Schwartz PJ, Crotti L. QTc behavior during exercise and genetic testing for the long-QT syndrome. Circulation. 2011;124:2181-4.
15. Barc J, Briec F, Schmitt S, Kyndt F, Le Cunff M, Baron E, et al. Screening for copy number variation in genes associated with the long QT syndrome: clinical relevance. J Am Coll Cardiol. 2011;57:40-7.
16. Grand T, Demion M, Norez C, Mettey Y, Launay P, Becq F, et al. 9-phenanthrol inhibits human TRPM4 but not TRPM5 cationic channels. Br J Pharmacol. 2008;153:1697-705.
17. Calabrese R, Capriotti E, Fariselli P, Martelli PL, Casadio R. Functional annotations improve the predictive score of human disease-related mutations in proteins. Hum Mutat. 2009;30:1237-44.
18. Capriotti E, Calabrese R, Casadio R. Predicting the insurgence of human genetic diseases associated to single point protein mutations with support vector machines and evolutionary information. Bioinformatics Oxf Engl. 2006;22:2729-34.
19. Bromberg Y, Rost B. SNAP: predict effect of non-synonymous polymorphisms on function. Nucleic Acids Res. 2007;35:3823-35.
20. Bendl J, Stourac J, Salanda O, Pavelka A, Wieben ED, Zendulka J, et al. PredictSNP: robust and accurate consensus classifier for prediction of disease-related mutations. PLoS Comput Biol. 2014;10:e1003440.
21. Stallmeyer B, Zumhagen S, Denjoy I, Duthoit G, Hébert J-L, Ferrer X, et al. Mutational spectrum in the Ca(2+)--activated cation channel gene TRPM4 in patients with cardiac conductance disturbances. Hum Mutat. 2012;33:109-17.
22. Chen L, Marquardt ML, Tester DJ, Sampson KJ, Ackerman MJ, Kass RS. Mutation of an A-kinase-anchoring protein causes long-QT syndrome. Proc Natl Acad Sci U S A. 2007;104:20990-5.
23. de Villiers CP, van der Merwe L, Crotti L, Goosen A, George AL, Schwartz PJ, et al. AKAP9 is a genetic modifier of congenital long-QT syndrome type 1. Circ Cardiovasc Genet. 2014;7:599-606.
24. Crotti L, Johnson CN, Graf E, De Ferrari GM, Cuneo BF, Ovadia M, et al. Calmodulin mutations associated with recurrent cardiac arrest in infants. Circulation. 2013;127:1009-17.
25. Makita N, Yagihara N, Crotti L, Johnson CN, Beckmann B-M, Roh MS, et al. Novel calmodulin mutations associated with congenital arrhythmia susceptibility. Circ Cardiovasc Genet. 2014;7:466-74.
26. Simard C, Hof T, Keddache Z, Launay P, Guinamard R. The TRPM4 non-selective cation channel contributes to the mammalian atrial action potential. J Mol Cell Cardiol. 2013;59:11-9.
27. Mathar I, Kecskes M, Van der Mieren G, Jacobs G, Camacho Londoño JE, Uhl S, et al. Increased β-adrenergic inotropy in ventricular myocardium from Trpm4-/- mice. Circ Res. 2014;114:283-94.
28. Andelfinger G, Tapper AR, Welch RC, Vanoye CG, George AL, Benson DW. KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes. Am J Hum Genet. 2002;71:663-8.
29. Splawski I, Timothy KW, Sharpe LM, Decher N, Kumar P, Bloise R, et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell. 2004;119:19-31.